DNAME-IT HOLDINGS LIMITED

Active London

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
D

DNAME-IT HOLDINGS LIMITED

Research and experimental development on biotechnology

Founded 19 Dec 2022 Active London, England 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 5 months remaining
Confirmation Submitted 18 Mar 2026 Next due 11 Mar 2027 10 months remaining
Net assets £2M £33K 2024 year on year
Total assets £2M £9K 2024 year on year
Total Liabilities £30K £25K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

25 Old Burlington Street London W1S 3AN England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for DNAME-IT HOLDINGS LIMITED (14547658), an active life sciences and medical technology company based in London, England. Incorporated 19 Dec 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Decreased by £64.57k (-100%)

Net Assets

£1.86M

Decreased by £33.38k (-2%)

Total Liabilities

£29.88k

Increased by £24.55k (+461%)

Turnover

N/A

Employees

N/A

Debt Ratio

2%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jun 2023Seed
Investor 2Jun 2023Seed

Share Capital

Share Capital

Share allotments and capital structure

14 Allotments 1,053,579 Shares £91632.54m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jan 202630,685£87k£2.85
30 Jan 202630,685£87k£2.85
16 Jan 202617,282£49k£2.85
31 Dec 2025275,715£786k£2.85
9 Dec 202536,583£104k£2.85

Officers

Officers

3 active
Status
Crowe, Stephen DanielDirectorBritishUnited Kingdom5319 Dec 2022Active
Cuppens, HarryDirectorBelgianBelgium6030 Jun 2023Active
Dean, Kevin JohnDirectorBritishUnited Kingdom6116 Feb 2026Active

Shareholders

Shareholders (5)

Frontier Biosciences Limited
37.8%
808,000
Mnl Nominees Limited
34.5%
739,393

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased
Active
Notified 19 Dec 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Active
Notified 30 Jan 2026
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Harry Cuppens

Ceased 30 Jun 2023

Ceased

Group Structure

Group Structure

APEX UNITAS LIMITED united kingdom
MNL NOMINEES LIMITED united kingdom
EMV CAPITAL PLC united kingdom
DNAME-IT HOLDINGS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Mar 2026Confirmation StatementConfirmation statement made on 2026-02-25 with updates
17 Mar 2026Persons With Significant ControlMnl Nominees Limited notified as a person with significant control
20 Feb 2026CapitalAllotment of shares (GBP 21,401.12) on 2026-01-30
20 Feb 2026CapitalAllotment of shares (GBP 21,267.09) on 2026-01-16
20 Feb 2026CapitalAllotment of shares (GBP 21,573.94) on 2026-01-30
18 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-02-25 with updates

17 Mar 2026 Persons With Significant Control

Mnl Nominees Limited notified as a person with significant control

20 Feb 2026 Capital

Allotment of shares (GBP 21,401.12) on 2026-01-30

20 Feb 2026 Capital

Allotment of shares (GBP 21,267.09) on 2026-01-16

20 Feb 2026 Capital

Allotment of shares (GBP 21,573.94) on 2026-01-30

Recent Activity

Latest Activity

Confirmation statement made on 2026-02-25 with updates

1 months ago on 18 Mar 2026

Mnl Nominees Limited notified as a person with significant control

1 months ago on 17 Mar 2026

Allotment of shares (GBP 21,401.12) on 2026-01-30

1 months ago on 20 Feb 2026

Allotment of shares (GBP 21,267.09) on 2026-01-16

1 months ago on 20 Feb 2026

Allotment of shares (GBP 21,573.94) on 2026-01-30

1 months ago on 20 Feb 2026